Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
vinCRIStine-DOXOrubicin
vinCRIStine-DOXOrubicin
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS |
Last updated: Feb. 24, 2023
- High Alert: CAUTION: See High-Alert Medication Policy
- Antineoplastic HD PPE and Disposal (vincristine)
- Antineoplastic HD PPE and Disposal (doxorubicin)
- Antineoplastic HD Hazardous Drug Safe Handling Policy
- Black Box Warning: Vincristine: IV use only (fatal intrathecally)
- Black Box Warning: Doxorubicin: Cardiac, hepatic, myelosuppression, extravasation risk
Safe Administration and Handling of Chemotherapy: See Policy 906.4802
Chemotherapy Preparation:
Preparation, Handling, Labeling, Dispensing and Disposal of Cytotoxic Drugs: Policy 916.4415
LH Pharmacy Services Chemotherapy Standards